Harbor Medtech

Bio-engineered tissue regeneration for advanced care of topical and surgical wounds, including DFU, VLU, hernias, bariatric surgery.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Irvine, CA, USA
  • Currency USD
  • Founded July 2010
  • Employees 6
  • Website harbormedtech.com

Company Summary

Harbor is commercializing proprietary bio-engineered therapies that help regenerate tissue damaged or lost from trauma, disease, or surgery. Our first product will be an advanced biologic wound care product, at a much lower cost, for diabetic foot ulcers and other serious, chronic topical wound. It will be FDA cleared in 2012. Our next product will be a biologic surgical mesh that bio-engineered to resorb at the same rate the wound heals.

Team

  • Jerry Mezger
    President & CEO

    Mezger has previously run 7 other medical technology companies that are now part of 3M, Medtronic, Radiometer and Covidien (EndiCor Medical). Very strong entreprenuer who has built companies in a very capital efficient manner to protect investor value. Has worked with Gregg Stone and others in the past

  • Jim Jungwirth
    CFO

  • Keith Myers
    CTO

    20+ years developing and manufacturing biologic products at Baxter, 3F (now Medtronic) and Pegasus Biologics. Inventor of Harbor's technology

  • Santino Costanzo
    VP Sales

    Led the team that commercialized and built Apligraf to over $1 billion in sales over the past 10 years.

  • Jerry Mezger

Advisors

  • Stradling Yocca Carlson Rauth
    Lawyer
    Unconfirmed

Previous Investors

  • Private investors have put in about $1.5 million
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free